TherapeuticsMD (TXMD) Other financing activities (2010 - 2023)

TherapeuticsMD's Other financing activities history runs 13 years deep, the most recent figure standing at -$1.1 million for Q3 2023.

• Quarterly Other financing activities fell 8007.14% year-over-year to -$1.1 million in Q3 2023, while the trailing twelve-month figure through Mar 2024 was -$1.1 million (down 200.0% YoY) and the FY2021 annual result came in at $322000.0, down 74.24% from the prior year.
• Other financing activities was -$1.1 million for Q3 2023 at TherapeuticsMD, down from $1000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $6.6 million in Q3 2019 and bottomed at -$6.5 million in Q4 2019.
• A 5-year average of $112066.7 and a median of $50000.0 in 2021 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2019 — Other financing activities surged 6005.43% — and 2023, when it plunged 8007.14%.
• TherapeuticsMD's Other financing activities stood at -$6.5 million in 2019, then jumped by 116.57% to $1.1 million in 2020, then slumped by 542.44% to -$4.8 million in 2021, then surged by 99.71% to -$14000.0 in 2022, then tumbled by 7807.14% to -$1.1 million in 2023.
• Business Quant data shows TXMD's Other financing activities at -$1.1 million in Q3 2023, $1000.0 in Q2 2023, and $1.1 million in Q1 2023.